G. Coppolino

534 total citations
18 papers, 417 citations indexed

About

G. Coppolino is a scholar working on Immunology, Rheumatology and Surgery. According to data from OpenAlex, G. Coppolino has authored 18 papers receiving a total of 417 indexed citations (citations by other indexed papers that have themselves been cited), including 6 papers in Immunology, 5 papers in Rheumatology and 4 papers in Surgery. Recurrent topics in G. Coppolino's work include Systemic Lupus Erythematosus Research (5 papers), Diabetes Management and Research (4 papers) and Diabetes and associated disorders (4 papers). G. Coppolino is often cited by papers focused on Systemic Lupus Erythematosus Research (5 papers), Diabetes Management and Research (4 papers) and Diabetes and associated disorders (4 papers). G. Coppolino collaborates with scholars based in Italy, Netherlands and Germany. G. Coppolino's co-authors include Antonella Afeltra, Marta Vadacca, Fabio Cacciapaglia, Maria P. Abbracchio, Davide Lecca, Antonio Amoroso, Domenico Paolo Emanuele Margiotta, Davide Marangon, Amelia Rigon and Marta Fumagalli and has published in prestigious journals such as PLoS ONE, Scientific Reports and Annals of the New York Academy of Sciences.

In The Last Decade

G. Coppolino

18 papers receiving 409 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
G. Coppolino Italy 12 119 110 103 65 56 18 417
S. Sallmann Germany 8 134 1.1× 101 0.9× 60 0.6× 16 0.2× 38 0.7× 10 396
Alexandru Tatomir United States 13 132 1.1× 162 1.5× 32 0.3× 15 0.2× 55 1.0× 29 440
Rainer Akkermann Germany 11 131 1.1× 175 1.6× 20 0.2× 111 1.7× 34 0.6× 14 439
Darlene Badgett United States 13 213 1.8× 140 1.3× 152 1.5× 30 0.5× 49 0.9× 18 657
Giorgia Leone Italy 12 124 1.0× 34 0.3× 29 0.3× 16 0.2× 27 0.5× 18 451
H Kikuchi Japan 13 185 1.6× 25 0.2× 35 0.3× 36 0.6× 98 1.8× 36 523
Javad Rasouli United States 12 207 1.7× 254 2.3× 31 0.3× 45 0.7× 33 0.6× 16 604
Makoto Hayase Japan 8 153 1.3× 45 0.4× 16 0.2× 47 0.7× 67 1.2× 31 429
M. Rieks Germany 7 113 0.9× 102 0.9× 22 0.2× 33 0.5× 24 0.4× 9 453
F Stivala Italy 11 233 2.0× 130 1.2× 19 0.2× 19 0.3× 35 0.6× 19 558

Countries citing papers authored by G. Coppolino

Since Specialization
Citations

This map shows the geographic impact of G. Coppolino's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by G. Coppolino with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites G. Coppolino more than expected).

Fields of papers citing papers by G. Coppolino

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by G. Coppolino. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by G. Coppolino. The network helps show where G. Coppolino may publish in the future.

Co-authorship network of co-authors of G. Coppolino

This figure shows the co-authorship network connecting the top 25 collaborators of G. Coppolino. A scholar is included among the top collaborators of G. Coppolino based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with G. Coppolino. G. Coppolino is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

18 of 18 papers shown
1.
Paladini, Maria Serena, Davide Marangon, A.C. Rossetti, et al.. (2020). Prenatal Stress Impairs Spinal Cord Oligodendrocyte Maturation via BDNF Signaling in the Experimental Autoimmune Encephalomyelitis Model of Multiple Sclerosis. Cellular and Molecular Neurobiology. 42(4). 1225–1240. 9 indexed citations
2.
Parravicini, Chiara, Davide Lecca, Davide Marangon, et al.. (2020). Development of the first in vivo GPR17 ligand through an iterative drug discovery pipeline: A novel disease-modifying strategy for multiple sclerosis. PLoS ONE. 15(4). e0231483–e0231483. 19 indexed citations
3.
Coppolino, G., Davide Marangon, Camilla Negri, et al.. (2018). Differential local tissue permissiveness influences the final fate of GPR17‐expressing oligodendrocyte precursors in two distinct models of demyelination. Glia. 66(5). 1118–1130. 40 indexed citations
4.
Fumagalli, Marta, Davide Lecca, G. Coppolino, Chiara Parravicini, & Maria P. Abbracchio. (2017). Pharmacological Properties and Biological Functions of the GPR17 Receptor, a Potential Target for Neuro-Regenerative Medicine. Advances in experimental medicine and biology. 1051. 169–192. 31 indexed citations
5.
Parravicini, Chiara, Simona Daniele, Luca Palazzolo, et al.. (2016). A promiscuous recognition mechanism between GPR17 and SDF-1: Molecular insights. Cellular Signalling. 28(6). 631–642. 12 indexed citations
6.
Lecca, Davide, Davide Marangon, G. Coppolino, et al.. (2016). MiR-125a-3p timely inhibits oligodendroglial maturation and is pathologically up-regulated in human multiple sclerosis. Scientific Reports. 6(1). 34503–34503. 58 indexed citations
7.
Vadacca, Marta, et al.. (2011). Neuropsychiatric Lupus Erythematosus. Reumatismo. 58(3). 177–86. 7 indexed citations
8.
Vadacca, Marta, Roberto Bruni, Francesco Serino, et al.. (2011). Alexithymia and immunoendocrine parameters in patients affected by systemic lupus erythematosus and rheumatoid arthritis. Reumatismo. 60(1). 12 indexed citations
9.
Cacciapaglia, Fabio, Enrico Maria Zardi, G. Coppolino, et al.. (2009). Stiffness parameters, intima-media thickness and early atherosclerosis in systemic lupus erythematosus patients. Lupus. 18(3). 249–256. 40 indexed citations
10.
Vadacca, Marta, Domenico Paolo Emanuele Margiotta, Amelia Rigon, et al.. (2009). Adipokines and Systemic Lupus Erythematosus: Relationship with Metabolic Syndrome and Cardiovascular Disease Risk Factors. The Journal of Rheumatology. 36(2). 295–297. 81 indexed citations
11.
Cacciapaglia, Fabio, Marta Vadacca, G. Coppolino, et al.. (2007). Spontaneous splenorenal shunt in a patient with antiphospholipid syndrome: the first case reported. Lupus. 16(1). 56–58. 8 indexed citations
12.
Zardi, Enrico Maria, Domenico Borzomati, Fabio Cacciapaglia, et al.. (2007). Percutaneous ultrasound-guided ablation of BW7756-hepatoma using ethanol or acetic acid in a rat model. BMC Gastroenterology. 7(1). 45–45. 4 indexed citations
13.
Amoroso, Antonio, Fabio Cacciapaglia, G. Coppolino, et al.. (2006). The adjunctive role of antiphospholipid antibodies in systemic lupus erythematosus cardiac involvement.. PubMed. 24(3). 287–94. 17 indexed citations
14.
Bruni, Roberto, Francesco Serino, Sara Galluzzo, et al.. (2006). Alexithymia and Neuroendocrine‐ Immune Response in Patients with Autoimmune Diseases. Annals of the New York Academy of Sciences. 1069(1). 208–211. 25 indexed citations
15.
Pozzilli, Paolo, et al.. (2005). Biokinetics of buccal spray insulin in patients with type 1 diabetes. Metabolism. 54(7). 930–934. 22 indexed citations
16.
Pozzilli, Paolo, Antonino Crinò, Riccardo Schiaffini, et al.. (2003). A 2-Year Pilot Trial of Continuous Subcutaneous Insulin Infusion Versus Intensive Insulin Therapy in Patients with Newly Diagnosed Type 1 Diabetes (IMDIAB 8). Diabetes Technology & Therapeutics. 5(6). 965–974. 27 indexed citations
17.
Crinò, Antonino, Maria Gisella Cavallo, C Mesturino, et al.. (2001). Intradermal skin test with diabetes specific antigens in patients with type 1 diabetes. Clinical & Experimental Immunology. 123(3). 382–386. 1 indexed citations
18.
Crinò, Antonino, Paolo Ciampalini, S. Spera, et al.. (2000). No effect of oral insulin on residual beta-cell function in recent onset type 1 diabetes. 2. 18. 4 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026